Company Filing History:
Years Active: 2018-2020
Title: Mark C. Wilkes: Innovator in Polypeptide Inhibitors
Introduction
Mark C. Wilkes is a notable inventor based in Plainview, MN (US). He has made significant contributions to the field of medical research, particularly in the development of polypeptide inhibitors. With a total of 2 patents, his work focuses on innovative methods to treat diseases through advanced biotechnological approaches.
Latest Patents
One of Mark C. Wilkes' latest patents is centered around polypeptide inhibitors of SMAD3 polypeptide activities. This patent outlines methods and materials for utilizing polypeptides designed to include both a cell-penetrating amino acid sequence and an amino acid segment of a SH3 domain of a SNX9 polypeptide. These innovations aim to inhibit one or more Smad3 polypeptide activities. Additionally, the patent provides methods for using RNA interference to treat diseases, such as fibrotic diseases, in mammals, including humans.
Career Highlights
Mark C. Wilkes is associated with the Mayo Foundation for Medical Education and Research, where he continues to advance his research in the field of medical innovations. His work has the potential to impact the treatment of various diseases significantly.
Collaborations
Mark has collaborated with esteemed colleagues, including Edward B. Leof and Claire E. Repellin, who contribute to the research and development of his innovative projects.
Conclusion
Mark C. Wilkes stands out as an influential inventor in the realm of polypeptide inhibitors, with his work promising advancements in medical treatments. His contributions reflect the importance of innovation in addressing complex health challenges.